A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

Memorial Sloan Kettering Cancer Center, New York

Thomas Jefferson University, Philadelphia

University of North Carolina, Chapel Hill

Sarah Cannon Cancer Center, Nashville

Cleveland Clinic Foundation, Cleveland

University of Michigan, Ann Arbor

University of Chicago Medicine-Comprehensive Cancer Center, Chicago

Centre Leon Berard, Lyon

University of Texas MD Anderson Cancer Center, Houston

UCLA Medical Center, Los Angeles

UCSF Medical Center at Mission Bay, San Francisco

Institut Gustave Roussy (Igr), Villejuif

Emory University, Atlanta

Massachusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston

Ohio State University Hospital, Columbus